Despite operating in different industry sectors, several multinational companies share a common goal of stepping up investment in China's high-tech and supply chain sectors to stay competitive.
The PMI of China's manufacturing sector registered a one-year high in March, signaling the resilience and upward momentum of the world's second-largest economy despite global headwinds.
Against the backdrop of geopolitical tensions and growing waves of trade protectionism, foreign enterprises are doubling down on their commitment to China due to the country's economic resilience.
A roadshow of the third China International Supply Chain Expo (CISCE) was held Tuesday in Milan, Italy, with bilateral cooperation highlighted and cooperation agreements signed.
The ongoing 2025 Zhongguancun Forum (ZGC Forum) Annual Conference highlights the transformation of Zhongguancun, China's "Silicon Valley," into a global innovation hub, marked by groundbreaking technologies and the convergence of global expertise.
Riding the wave of China's high-level opening-up, foreign companies are leveraging the advantages of the world's second-largest economy and participating in its innovation pursuit, to achieve win-win cooperation.
Chinese software developers' creativeness is "second to none", and more Chinese mobile applications will succeed globally with greater international influence, Apple CEO Tim Cook said on Tuesday in Beijing.
From the China Development Forum 2025 in Beijing to the Boao Forum for Asia Annual Conference 2025 in south China's Hainan Province, foreign executives have reaffirmed their commitment to China as a key market for investment and collaboration.
After learning that a U.S.-developed drug could be accessed in Boao Lecheng International Medical Tourism Pilot Zone just three months, a foreign delegate at the Boao Forum for Asia Annual Conference hailed Lecheng as "China's gateway to global healthcare."
An increasing number of foreign-funded enterprises are seizing development opportunities in China's new energy vehicle sector by boosting investment, expanding their market presence, and advancing projects, research and cooperation.
The rapid development of artificial intelligence technology is proving to be a key driver of the nation's high-quality growth, noted international industry experts at a key forum.
Multinational pharmaceutical firms, particularly U.S. giants, are increasingly recognizing China's burgeoning innovative drug sector as a strategic goldmine to bolster their global competitiveness.
Guest speakers at the Symposium on Macro Policies and Economic Growth at the China Development Forum (CDF) 2025 expressed optimism about China's economy despite global uncertainties.
Heads of some 80 multinationals including Siemens, Apple, Samsung and Pfizer have flocked to China to seek new cooperation opportunities with the world's second-largest economy.
China is riding the wave of an AI-powered transformation. As AI reshapes industries and daily life, it is not only driving automation and increasing efficiency but also unlocking new possibilities.
China will work to further stabilize foreign investment in 2025, implementing measures to open up more fields and improve the business environment, the Ministry of Commerce said on Thursday.
